http://www.technologyreview.com/Biotech/19039/ Technology is quickly gathering tools to help in characterizing the cell surface antigens that play a central role in cancer. We will create molecules that will "label" a cancer cell as producing
[I've taken the plunge and bought myself an online subscription to Nature and 50+ other publications they produce. This will mean more posts on this blog] This is a quick read. The researchers found that beta-catenin was over-expressed in skin cancer while in normal stem cells, it is only expressed periodically. This falls inline with the CRF theory. Beta-catenin is an essential player in how the cell reprograms itself by implementing epigenetic changes. Clearly, a cancer cell, having difficulty establishing contact with the proper CRF's, might continue to express beta-catenin because the embryonic CRF's are nowhere to be found. Baker, M. Skin cancer needs beta-catenin. Nat Rep Stem Cells (2008). https://doi.org/10.1038